Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST)

Historical Holders from Q2 2019 to Q3 2025

Symbol
MIST on Nasdaq
CUSIP
59935V107
Type / Class
Equity / Common Shares, no par value per share
Shares outstanding
92.5M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
34.1M
Holdings value
$68.3M
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
61
Number of buys
44
Number of sells
-11
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RTW INVESTMENTS, LP 9.9% -0.9% $18.3M $7.03M 9.16M +62.3% RTW Investments, LP Sep 30, 2025
Trails Edge Capital Partners, LP 9.9% 0% $18M $340K 9.02M +1.92% Trails Edge Capital Partners, LP Sep 30, 2025
Adage Capital Management, L.P. 9.99% $17.3M 8.66M Adage Capital Management, L.P. Sep 30, 2025
INTEGRATED CORE STRATEGIES (US) LLC 0.6% $248K 322K Integrated Core Strategies (US) LLC Mar 31, 2025

Institutional Holders of Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 34.1M $68.3M +$44.8M $2.00 61
2025 Q2 11.8M $22.9M +$893K $1.94 43
2025 Q1 11.8M $9.46M -$26M $0.80 43
2024 Q4 24.5M $57.9M -$9.79M $2.36 46
2024 Q3 28.7M $43.6M -$2.29M $1.52 41
2024 Q2 30.2M $39.9M -$1.77M $1.32 40
2024 Q1 31.1M $55.6M +$23.7M $1.79 40
2023 Q4 20K $33.4K -$313K $1.67 1
2023 Q3 19.4M $60M -$3.31M $3.10 37
2023 Q2 20.5M $58.3M -$3.17M $2.85 46
2023 Q1 21.5M $84.7M -$10.2M $3.94 47
2022 Q4 23.7M $93.7M -$29.5M $3.96 53
2022 Q3 20.4M $187M +$9.68M $9.19 42
2022 Q2 20.8M $127M -$2.81M $6.14 28
2022 Q1 20.2M $130M +$5.07M $6.42 26
2021 Q4 19.4M $127M +$2M $6.55 25
2021 Q3 19.9M $114M -$1.09M $5.71 29
2021 Q2 20.1M $111M -$855K $5.50 30
2021 Q1 20.3M $117M -$1.99M $5.79 31
2020 Q4 20.6M $138M +$34M $6.70 32
2020 Q3 15.5M $113M +$42.8M $7.32 28
2020 Q2 9.74M $36.8M +$2.94M $3.78 22
2020 Q1 9.23M $17M -$32.7M $1.84 15
2019 Q4 14.4M $230M +$20.2M $16.01 23
2019 Q3 13.1M $240M -$2.84M $18.65 22
2019 Q2 13.1M $350M +$350M $27.15 23